The company in question is, *TBA (NASDAQ:VRTX) currently with a stock price of 117.26 (2.29% today). The market cap for *TBA is 29132.07, and is in the sector Healthcare, and Biotechnology industry. The target price for *TBA is 114.38. Currently *TBA is trading with a P/E of *TBA, and a forward P/E of 37.84. Average volume for *TBA is 1861.6 and so far today it is 1495498.
Performance in the last year for *TBA has been 39.41%. For EPS growth, *TBA has seen a growth of 80.10%, and is looking to grow in the next year to 91.77%. More long term stats show that EPS growth has been -39.40% over the last five years and could be 72.39% for the next five years. *TBA has seen sales growth quarter over quarter at 9.80%, with EPS growth quarter over quarter at 144.30%. The 20-day simple moving average is 9.63%, with the 200-day simple moving average coming to 30.94%.
Since the IPO date for *TBA on the 7/24/1991, *TBA has seen performance year to date to be 59.17%. With *TBA trading at 117.26, the dividend yield is *TBA, and the EPS is -0.46.
So could *TBA, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 17.11 and the P/B is at 24.84. The P/cash is 20.31, with P/free cash flow at 162.3.
*TBA ability to deal with debt shows that the current ratio is 2.3, and the quick ratio is 2.2. This is with long term debt/equity at 0.45, and total debt/equity at 0.73.
In terms of margins, *TBA has a gross margin of 87.90%, an operating margin of 0.60% and a profit margin of -6.60%.Payout ratio for *TBA is *TBA. Return on assets come to -4.30% with return on investment coming to -0.30%.
Insider ownership for *TBA, is at 0.50% and institutional ownership comes to 96.60%. Outstanding shares are at 248.44. While shares float is 246.59. The float short is currently 1.85%, and short ratio is 2.45.
Graphs: *TBA NASDAQ: VRTX | Friday April 21, 2017
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.